Osei Group Kurs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Osei group kurs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Osei Group Kurs Today - Breaking & Trending Today

Nxera Pharma is the New Name for Sosei Group

01.04.2024 - New name expresses the Company’s vision to lead the next era of medicine - from Japan, for Japan, and by extension, to the world – and its mission to accelerate the development of life-changing medicines, by investing in science and technologySosei . Seite 1 ....

Chris Cargill , Nxera Pharma , Idorsia Pharmaceuticals Japan , Nxera Pharma United Kingdom , Nxera Pharma Co Ltd , Idorsia Pharmaceuticals Japan Ltd , Nxera Pharma Japan Co Ltd , Sosei Group Corporation , Idorsia Pharmaceuticals Korea Co Ltd , Nxera Pharma Korea Co Ltd , Sosei Group To Nxera Pharma , Heptares Therapeutics Ltd , Sosei Group , Heptares Therapeutics , Pharmaceuticals Japan , Life Itself , Sosei Group Chart , Osei Group Kurs , Osei Group Aktie ,

Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office Seite 1

16.02.2024 - Tokyo, Japan and Cambridge, UK, 16 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), today announces that at a meeting held on 15 February 2024, its Board of Directors resolved to change the corporate names of . Seite 1 ....

Nxera Pharma United Kingdom , Idorsia Pharmaceuticals Japan Ltd , Idorsia Pharmaceuticals Korea Co Ltd , Nxera Pharma Japan Co Ltd , Sosei Co , Sosei Group Corporation , Nxera Pharma Co Ltd , Nxera Pharma Korea Co Ltd , Heptares Therapeutics Ltd , Ordinary General Meeting , Sosei Group Chart , Osei Group Kurs , Osei Group Aktie ,

Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2023

13.02.2024 - Tokyo, Japan and Cambridge, UK, 13 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the 12 months ended 31 December 2023. The . Seite 1 ....

United Kingdom , Sosei Heptares , Chris Cargill , Sosei Group , Sosei Group Corporation Heptares , Sosei Group Corporation , Sosei Group Chart , Osei Group Kurs , Osei Group Aktie ,

Sosei Heptares' President & CEO Chris Cargill Wins Executive of the Year at the Citeline Pharma Intelligence Awards Japan 2023 Seite 1

18.10.2023 - Tokyo, Japan, and Cambridge, UK, 18 October 2023 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), an international biopharmaceutical company and world-leader in GPCR-focused structure-based drug design (SBDD) and . Seite 1 ....

United Kingdom , Chris Cargill , Sosei Heptares , Tokyo Stock Exchange , Tokyo Stock , Sosei Group Chart , Osei Group Kurs , Osei Group Aktie ,

Sosei Heptares' partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of NBI-1117570 in Healthy Adults Seite 1

12.09.2023 - NBI-1117570 is an investigational, oral, muscarinic M1/M4 selective dual agonist discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNBI-1117570 is the second compound to advance into . Seite 1 ....

United Kingdom , Sosei Heptares , Neurocrine Biosciences , Sosei Heptare , Eiryw Roberts , Matt Barnes , Neurocrine Biosciences Inc , Sosei Group Corporation The Company , Sosei Group Corporation , Chief Medical Officer , Heptares Therapeutics , Sosei Group Chart , Osei Group Kurs , Osei Group Aktie ,